HeXun Biosciences Co., Ltd.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

53

Website

www.hexunbio.com

Country

Taiwan

Exchange

Taipei Exchange

Founded 2019

HeXun Biosciences provides the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan. It provides contract manufacturing. Its portfolio also includes commissioned inspection, aseptic filling, and consulting services. Founded in 2019, the company is based in Taoyuan City, Taiwan.

Key Stats

52-Week Range

NT$43.00NT$72.00

Beta0.07

Trailing P/E17.94

Forward P/EN/A

Trailing EPS2.43

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.